Form 4: Lemaitre Vascular Director John A. Roush Reports Changes in Beneficial Ownership

Director John A. Roush reports acquisition of dividend equivalent rights related to restricted stock unit awards.

Summary

• On August 29, 2024, John A. Roush, a director of Lemaitre Vascular Inc. (LMAT), reported changes in beneficial ownership.
• The reported transactions involve the acquisition of dividend equivalent rights related to previously granted restricted stock unit (RSU) and Performance Share Unit (PSU) awards.
• These dividend equivalent rights are economically equivalent to shares of Lemaitre Vascular's common stock and vest proportionately with the underlying awards.
• The dividend equivalent rights were acquired on RSUs granted on December 11, 2021 (0.358 rights), December 12, 2022 (0.7254 rights), and December 8, 2023 (0.9285 rights), as well as on PSUs granted on December 12, 2022 (0.7254 rights).
• Following the reported transactions, Roush directly owns 7.6743, 7.4911, 6.5024 and 3.2056 dividend equivalent rights respectively.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects routine compensation adjustments and alignment of director interests with shareholders.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity related to previously granted equity compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on shareholder confidence as it demonstrates the director's continued stake in the company's performance.

Key Dates